Showing 1 - 10 of 880
Recent years have seen the beginning of an industrial revolution in healthcare delivery. Healthcare is being transformed from a cottage industry, in which each provider sets individual standards, to a quality-controlled enterprise with common, evidence-based standards of care. Disease management...
Persistent link: https://www.econbiz.de/10005243032
Background: In 1996, the provincial government in Ontario, Canada required pharmaceutical manufacturers seeking to list their products on the provincial formulary to provide a formal economic analysis documenting the products' cost effectiveness. The provincial formulary lists pharmaceutical...
Persistent link: https://www.econbiz.de/10005243185
Telemedicine is a communications technology that can be expected to influence investment in equipment, the delivery and organisation of health services and outcomes of healthcare. Analysis of the economic impact of telemedicine has so far been limited and has focused on cost studies for...
Persistent link: https://www.econbiz.de/10005448773
Breast cancer is the most frequently diagnosed cancer in women and the second leading cause of cancer mortality. It is estimated to account for approximately 20% of all cancer expenditures, making the burden of disease relatively high. One of the most important risk factors for developing breast...
Persistent link: https://www.econbiz.de/10005448792
There are 3 demand sources in healthcare systems: the patient, provider and payor. Patient-determined demand is characterised as `random access' and emotionally charged. Provider-determined demand occurs within working environments that do not inherently support integration activities....
Persistent link: https://www.econbiz.de/10005448834
Recent best practice guidelines recommend the provision of psychosocial family interventions for families of adults with schizophrenia. This article delineates the various family interventions and the empirical base of these interventions. These interventions include psychoeducation, family...
Persistent link: https://www.econbiz.de/10005448942
Objectives: This study examines the organisational structure of pharmacoeconomics departments in major pharmaceutical and biotechnology companies, the impediments to optimal use of pharmacoeconomic evaluations by companies and the integration of pharmacoeconomic analysis with research and...
Persistent link: https://www.econbiz.de/10005449023
Persistent link: https://www.econbiz.de/10005449080
Persistent link: https://www.econbiz.de/10005449139
Objective: To investigate differences in attitudes, knowledge and actual use of economic evaluations in different groups of decision-makers, and to compare the results from the Netherlands with the overall European results of the European Network on Methodology and Application of Economic...
Persistent link: https://www.econbiz.de/10005449308